Eli Lilly May 2, 2026 Why Eli Lilly (LLY) Is Up 9.0% After Q1 Beat And Foundayo GLP‑1 Launch - And What's Next - simplywall.st
Eli Lilly May 1, 2026 While Mass. biotech layoffs surge, this pharma company is on a $20B buying spree - MassLive
Eli Lilly May 1, 2026 Eli Lilly: The Most Expensive Stock in Pharma; and Maybe the Best - TradingView
Eli Lilly May 1, 2026 Eli Lilly boss reports progress in India after Novo's patent expiration - medwatch.com
Eli Lilly Apr 30, 2026 Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket - Barron's
Eli Lilly Apr 30, 2026 Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch - BioPharma Dive
Eli Lilly Apr 30, 2026 Eli Lilly: Stellar Q1 Earnings Put Pharma In Class Of Its Own, It's Ok To Buy Today (LLY) - Seeking Alpha
Eli Lilly Apr 30, 2026 Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's - Fierce Pharma
Eli Lilly Apr 28, 2026 Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ - BioSpace
Eli Lilly Apr 28, 2026 Lilly pens $2.2B pact with Bezos-backed Profluent to work on recombinase-based gene editing - Fierce Biotech
Eli Lilly Apr 28, 2026 Profluent Announces Strategic Partnership with Lilly to Develop AI-Designed Recombinases for Genetic Medicine - Business Wire
Eli Lilly Apr 27, 2026 Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs - CNBC
Eli Lilly Apr 27, 2026 Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion in blood cancer bet - Reuters
Eli Lilly Apr 27, 2026 Lilly pens $2.3B deal for next-gen JAK inhibitor biotech Ajax - Fierce Biotech